YUEH-WEI SHEN

Yueh-Wei Shen has a strong background in scientific research and has held various roles in reputable companies. Their most recent position was as a Senior Scientist at Artiva Biotherapeutics, starting in March 2022. Prior to that, they worked as a Scientist at Fate Therapeutics Inc from May 2021 to April 2022. Before that, they held a Scientist role at Pfizer from September 2019 to November 2020.

Yueh-Wei Shen's career also includes significant experience at Kite Pharma, Inc., where they served as a Senior Associate Scientist from March 2014 to September 2019. In this role, they were responsible for providing PK data, developing assays, and leading pharmacokinetics analysis for clinical trials.

They began their career as a Research Associate II at City of Hope from October 2009 to March 2014, where they focused on Type 1 diabetes research and regulatory T cell functions. Prior to that, they worked as a Research Associate at Children's Memorial Hospital from January 2007 to October 2009, conducting molecular biology and gene-wide research on neural crest stem cells and their relationship with neural tube defects.

Overall, Yueh-Wei Shen has a diverse range of scientific research experience, including roles at pharmaceutical companies and research institutions.

Yueh-Wei Shen completed a Master's degree in Biology from Roosevelt University. This educational achievement took place between 2005 and 2007. Prior to that, they received a Bachelor's degree in Nutrition from Taipei Medical University, which they completed from 1998 to 2002.